Characteristics | Surgery + Chemotherapy | Chemotherapy | P |
---|---|---|---|
Age (years) | |||
≤ 60 | 25 (76) | 30 (88) | 0.13 |
> 60 | 8 (24) | 4 (12) | |
Performance status | |||
ECOG 0/1 | 27 (84) | 20 (59) | 0.03 |
ECOG ≥ 2 | 5 (16) | 14 (41) | |
Extranodal involvement | |||
< 2 | 15 (45) | 7 (21) | 0.04 |
≤ 2 | 18 (55) | 27 (79) | |
Serum LDH | |||
Normal | 17 (52) | 15 (44) | 0.62 |
Increased | 15 (45) | 19 (56) | |
Missing | 1 (3) | ||
Ann Arbor stage | |||
I/II | 15 (45) | 5 (15) | < 0.01 |
III/IV | 18 (55) | 29 (85) | |
B symptoms | |||
Absence | 15 (45) | 9 (27) | 0.13 |
Presence | 18 (55) | 25 (73) | |
Bone marrow invasion | |||
Absence | 29 (88) | 29 (85) | 0.20 |
Presence | 2 (6) | 5 (15) | |
Not evaluated | 2 (6) | 0 (0) | |
Nasal involvement | |||
Absence | 30 (91) | 19 (56) | < 0.01 |
Presence | 3 (9) | 15 (44) |